Literature DB >> 218686

The action of chlorpromazine at an isolated cholinergic synapse.

Z Argov, Y Yaari.   

Abstract

The effects of chlorpromazine (CPZ) on cholinergic transmission were studied at the isolated neuromuscular synapse of the frog. It was found that 5 x 10(-6) M CPZ produces the following effects: (1) a reduction in end-plate potential amplitude, mainly through inhibition of transmitter release at presynaptic nerve terminals; (2) a reduction in amplitude of focally recorded end-plate current without detectable change in nerve terminal potential: (3) a decrease in amplitude of miniature end-plate potentials; and (4) an increase in the frequency of spontaneous liberation of transmitter both in normal and calcium-free Ringer's solution. It is concluded that CPZ inhibits cholinergic transmission by a complex action on presynaptic and postsynaptic elements. The relation of these findings to central cholinergic activities of CPZ is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218686     DOI: 10.1016/0006-8993(79)90018-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Postsynaptic inhibitory effects of phenothiazines at cholinergic synapses may not involve calmodulin.

Authors:  Z Y Sahaf; S J Publicover
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

2.  Trifluoperazine-sensitive activation of the spontaneous transmitter release at the frog motor endplates by low doses of procaine.

Authors:  D D Brănişteanu; D D Brănişteanu; I D Haulică
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

3.  Effects of chlorpromazine and its dihydroxy metabolite on calcium movement and electrical activity in superior cervical ganglia.

Authors:  M Guzman-Harty; S A Tjioe; J J O'Neill
Journal:  Arch Toxicol       Date:  1985-02       Impact factor: 5.153

4.  Presynaptic action of trifluoperazine at the frog neuromuscular junction.

Authors:  S J Publicover
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

Review 5.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Function of a calmodulin in postsynaptic densities. III. Calmodulin-binding proteins of the postsynaptic density.

Authors:  R K Carlin; D J Grab; P Siekevitz
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.